Covered recipient · General Payments record
PATRICIA E KERESZTES-KORBER
Allopathic & Osteopathic Physicians Obstetrics & Gynecology
General Payments · PY2018–2024
$5,839.32
- Reported across 253 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $360.83 | 16 |
| Education | $84.99 | 1 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Astellas Pharma US Inc | $262.06 | 7 |
| PFIZER INC. | $160.39 | 8 |
| Exact Sciences Corporation | $15.29 | 1 |
| MAYNE PHARMA COMMERCIAL LLC | $8.08 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Astellas Pharma US Inc | $29.10 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139278224 | CMS |
| Astellas Pharma US Inc | $84.99 | 04/11/2024 | Education | Undisputed | 01/23/2026 | 1139346284 | CMS |
| Astellas Pharma US Inc | $34.67 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139339822 | CMS |
| Astellas Pharma US Inc | $29.82 | 07/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139281458 | CMS |
| Astellas Pharma US Inc | $25.41 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139388870 | CMS |
| Astellas Pharma US Inc | $29.52 | 10/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139426804 | CMS |
| Astellas Pharma US Inc | $28.55 | 12/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1139441574 | CMS |
| Exact Sciences Corporation | $15.29 | 07/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114731471 | CMS |
| MAYNE PHARMA COMMERCIAL LLC | $8.08 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1154707425 | CMS |
| PFIZER INC. | $26.26 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131592967 | CMS |
| PFIZER INC. | $22.24 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131592971 | CMS |
| PFIZER INC. | $21.18 | 07/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131593829 | CMS |
| PFIZER INC. | $7.74 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131593833 | CMS |
| PFIZER INC. | $19.20 | 09/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131997595 | CMS |
| PFIZER INC. | $24.05 | 10/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1130887463 | CMS |
| PFIZER INC. | $20.12 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131593837 | CMS |
| PFIZER INC. | $19.60 | 12/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131223722 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.